Clinical Trial Update: Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy [Phase 1]

View source ↗

Summary

A Phase 1 study of the investigational drug SB-509-0401 in subjects with diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• SB-509-0401

Snippet

Sponsor: Sangamo Therapeutics | Conditions: Diabetic Neuropathy | Phase 1 | Status: COMPLETED